🍽️ flurandrenolide,(prescription)

AI Engines For more Details: PerplexityKagi LabsYou

  1. Anti-inflammatory Effects: Flurandrenolide works by suppressing the immune response and reducing inflammation in the skin. It inhibits the production of inflammatory mediators, such as prostaglandins and leukotrienes, which play a role in the inflammatory process. By decreasing inflammation, flurandrenolide can alleviate symptoms such as redness, swelling, and discomfort.

  2. Itching Relief: Flurandrenolide helps relieve itching (pruritus) associated with skin conditions such as eczema (atopic dermatitis), psoriasis, allergic reactions, and dermatitis. It acts by reducing inflammation and suppressing the release of histamine and other itch-inducing substances in the skin, providing relief from itching and discomfort.

  3. Skin Disorders: Flurandrenolide is indicated for the treatment of various skin disorders, including eczema, psoriasis, allergic dermatitis, contact dermatitis, seborrheic dermatitis, and other inflammatory or allergic skin conditions. It is available in different formulations, including creams, ointments, lotions, and tapes, for topical application to affected areas of the skin.

  4. Dosage and Duration: The dosage and duration of treatment with flurandrenolide depend on the severity of the skin condition being treated, as well as individual patient factors such as age, skin type, and response to therapy. It is typically applied thinly and evenly to the affected area of the skin once or twice daily, as directed by a healthcare professional. Treatment duration may vary from a few days to several weeks, but prolonged use should be avoided to minimize the risk of adverse effects.

  5. Side Effects: Like other corticosteroids, flurandrenolide may cause side effects, particularly with prolonged or excessive use. Common side effects may include skin irritation, burning, stinging, itching, dryness, or redness at the site of application. In rare cases, systemic absorption of flurandrenolide may occur, leading to potential systemic side effects such as adrenal suppression, Cushing's syndrome, hyperglycemia (high blood sugar), glaucoma, cataracts, and skin thinning. Patients should be advised to use flurandrenolide sparingly and according to the prescribed regimen to minimize the risk of side effects.

  6. Precautions: Flurandrenolide should be used with caution in certain populations, including children, elderly individuals, pregnant or breastfeeding women, and patients with preexisting medical conditions such as diabetes, hypertension, or immune suppression. It should not be applied to broken or infected skin, and contact with the eyes, mouth, or mucous membranes should be avoided. Patients should be instructed to wash their hands thoroughly after applying flurandrenolide and to avoid occlusive dressings unless directed by a healthcare provider.

  7. Drug Interactions: Flurandrenolide may interact with other medications, particularly other corticosteroids or immunosuppressants, increasing the risk of systemic side effects or reducing the effectiveness of treatment. Patients should inform their healthcare providers about all prescription drugs, over-the-counter medications, vitamins, and herbal supplements they are taking before starting flurandrenolide therapy to minimize the risk of drug interactions and potential complications.

  8. Monitoring and Follow-up: Patients receiving flurandrenolide therapy should undergo regular monitoring of their skin condition and treatment response, as well as assessment for any signs of systemic side effects. Close collaboration between the patient and healthcare provider is essential to ensure the safe and effective use of flurandrenolide and to address any concerns or adverse reactions that may arise during treatment.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of flurandrenolide,(prescription) On Probiotics

Rank Probiotic Impact

Bacteria Impacted by flurandrenolide,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Roseburia genus Decreases 👪 Source Study
Mediterraneibacter genus Decreases 👪 Source Study
Segatella genus Decreases 👪 Source Study
unclassified Robinsoniella no rank Decreases ⚗️ Source Study
unclassified Fusobacterium no rank Decreases ⚗️ Source Study
unclassified Negativicoccus no rank Decreases ⚗️ Source Study
Eggerthellales order Decreases ⚗️ Source Study
Roseburia intestinalis species Decreases 📓 Source Study
[Ruminococcus] torques species Decreases 📓 Source Study
Anaerofustis stercorihominis species Decreases ⚗️ Source Study
Asaccharospora irregularis species Decreases ⚗️ Source Study
Negativicoccus sp. S5-A15 species Decreases ⚗️ Source Study
Paraprevotella clara species Decreases ⚗️ Source Study
Slackia sp. NATTS species Decreases ⚗️ Source Study
Pseudoflavonifractor capillosus species Decreases ⚗️ Source Study
[Collinsella] massiliensis species Decreases ⚗️ Source Study
Parvibacter caecicola species Decreases ⚗️ Source Study
Segatella copri species Decreases 📓 Source Study Over 70%ile Indicator of mycotoxin present
Coriobacterineae suborder Decreases ⚗️ Source Study
Chlamydiae/Verrucomicrobia group superphylum Decreases ⚗️ Source Study

Impact of flurandrenolide,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
ADHD 0.1 0.1
Age-Related Macular Degeneration and Glaucoma 0.1 0.1
Allergies 0 0
Alzheimer's disease 0.4 -0.4
Ankylosing spondylitis 0 0
Anorexia Nervosa 0.1 -0.1
Antiphospholipid syndrome (APS) 0.3 0.3
Asthma 0.1 -0.1
Atherosclerosis 0.4 -0.4
Atrial fibrillation 0 0
Autism 0.4 0.2 1
Bipolar Disorder 0.1 -0.1
Brain Trauma 0.1 -0.1
Cerebral Palsy 0.1 -0.1
Chronic Fatigue Syndrome 0.1 0.1
Chronic Kidney Disease 0.2 0.1 1
Chronic Lyme 0.1 -0.1
Chronic Obstructive Pulmonary Disease (COPD) 0.1 -0.1
Chronic Urticaria (Hives) 0 0
Coagulation / Micro clot triggering bacteria 0.1 -0.1
Colorectal Cancer 0.1 0.1
Constipation 0.1 -0.1
COVID-19 0.5 -0.5
Crohn's Disease 0.1 0.1 0
cystic fibrosis 0.1 -0.1
deep vein thrombosis 0.1 -0.1
Depression 0.5 0.1 4
Fibromyalgia 0.1 0 0
Functional constipation / chronic idiopathic constipation 0.3 0.4 -0.33
gallstone disease (gsd) 0.1 -0.1
Graves' disease 0.1 -0.1
Hashimoto's thyroiditis 0.4 0.4
hypertension (High Blood Pressure 0.1 -0.1
IgA nephropathy (IgAN) 0 0
Inflammatory Bowel Disease 0.5 -0.5
Insomnia 0.1 -0.1
Intelligence 0 0
Irritable Bowel Syndrome 0.1 0.1 0
Liver Cirrhosis 0.1 0.1 0
Long COVID 0.1 -0.1
Low bone mineral density 0.1 -0.1
ME/CFS without IBS 0.1 0.1
Metabolic Syndrome 0.1 0.1 0
Mood Disorders 0.5 0.1 4
Multiple Sclerosis 0.2 -0.2
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 0 0
Obesity 0.4 0.4
obsessive-compulsive disorder 0.3 -0.3
Parkinson's Disease 0.4 -0.4
Polycystic ovary syndrome 0.1 -0.1
Psoriasis 0.2 -0.2
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 0.2 0.1 1
Rosacea 0.2 0.1 1
Schizophrenia 0.1 -0.1
Sjögren syndrome 0 0
Sleep Apnea 0.1 -0.1
Stress / posttraumatic stress disorder 0.1 0.1 0
Systemic Lupus Erythematosus 0.1 -0.1
Tic Disorder 0 0
Type 1 Diabetes 0.1 -0.1
Type 2 Diabetes 0.1 0.1 0
Ulcerative colitis 0.2 -0.2
Unhealthy Ageing 0.2 0.1 1

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant or equivalent EU laws. [44.222.64 ]

Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [44.222.64 ]